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Nevanlinna HR (1972) The Finnish population structure: a geneticgenotype approaches. Thus, even if coding-sequence polymor-
and genealogical study. Hereditas 71:195–236phisms are detected, their sheer number may reduce drastically
Risch N, Merikangas K (1996) The future of genetic studies of com-
the sensitivity of such association studies. Weiss raises many plex human diseases. Science 273:1516–1517
such issues that affect the spectrum of complex-disease genet- Terwilliger JD, Ott J (1994) Handbook of human genetic linkage.
Johns Hopkins University Press, Baltimore, Londonics, and none of them is resolved fully. I wish that the author
had extrapolated more than he has about the ramiﬁcations of
 1997 by The American Society of Human Genetics. All rights reserved.his evolutionary model on our current approaches to mapping
0002-9297/97/6006-0043$2.00complex disease–predisposing genes and about how we might
improve current methods.
There are a great many practical reasons to understand the
concepts presented. We are spending millions of taxpayer dol-
lars on the genome screening of many different pedigree or
Am. J. Hum. Genet. 60:1566–1567, 1997population-based data sets for every potentially genetic trait.
Careful reviewmay be needed both to decide if this is a respon-
sible way to spend the money and to identify traits that may Gene Therapy: A Primer for Physicians. 2d ed. By Kenneth
be studied most effectively by use of this approach. As the Culver. Larchmont, NY: Mary Ann Liebert, Inc. Pp. 216.
author states, ‘‘a few rare alleles at major genes that affect a $59.00.
trait . . . are of little population importance’’ (p. 313). In
the context of the author’s prognostications about the large Human gene therapy has grown exponentially over the past de-
cade and has expanded into a ﬁeld including well over 100 clinicalnumber of different alleles predicted at each locus, one might
reconsider whether it is really sensible to invest millions of trials. As the number of trials has grown, so has the need for
practicing physicians to understand gene therapy, in order to bedollars to develop maps of biallelic markers spanning the ge-
nome, for the purposes of disequilibrium analysis. The author able to guide their patients. This book provides a unique resource,
since it attempts to educate both the physicians and the patientsadvocates thoughtfully planned experiments as the best invest-
ment. He writes: ‘‘Order can be found in the complexity if we who may be interested in participating in gene therapy trials. The
second edition includes expanded discussions of genetic diagnosisknow what to look for. I have tried to suggest that it is in the
context of evolution that we are being led to such a synthesis’’ and gene therapy technologies and provides updated information
in the appendices. The book begins with a brief introduction to the(p. 314). Drug-company executives contemplating a major in-
vestment in the isolation of an array of predisposing alleles of development of recombinant DNA and gene therapy technology,
followed by the methods used for gene transfer/gene therapy. Thehigh frequency and weak effect also should consider carefully
the arguments raised herein, to evaluate whether their invest- second section focuses on individual diseases and the techniques
used to treat themwith gene therapy. The bibliographies are exten-ment is ﬁscally prudent for each trait that they propose to
study. Many other issues are raised indirectly in the book, and sive and includemany of the most useful primary references. How-
ever, the choice of topics seems somewhat arbitrary. Whereas thereaders will ﬁnish with different concerns of their own. If a
good book is one that provokes the reader to think beyond the author stresses the importance of identifying disease genes, he
gives less attention to the fundamental technical challenge in geneprinted word, surely this is a book that satisﬁes that criterion.
Weiss, however, is not entirely pessimistic. Although he both therapy—that is, how to transport a large, highly charged mole-
cule (i.e., DNA) into the cell nucleus. A welcome addition wouldpoints out many issues that may prove to be stumbling blocks
in our efforts to understand the genetic basis of human disease be a table comparing and contrasting the efﬁciency of the various
techniques and vectors available for the transduction of cells inand explains why the ‘‘landscape is subtle and complex’’
(p. 306), he provides reassurance: ‘‘Clearly, as mass genotyp- culture or in vivo. There are a few inaccuracies; for example, in
the section on cancer gene therapy, the description of ‘‘sensitivity’’ing technology becomes available, along with a more complete
polymorphic map, we will be able to document an increasing enzymes, which would render a cell susceptible to chemotherapy
(e.g., thymidine kinase/ganciclovir treatment), omits several im-fraction of the alleles that have consistently strong effects’’ (p.
306). Although these rare alleles of strong effect do not explain portant enzymes and misstates the relative potencies of different
systems. The section on ethical issues in gene therapy is quite shortmuch of the general population variability in which Weiss is
primarily interested, as Weiss does admit, these identiﬁable but does highlight the major points.
The third section includes appendices, which include some ex-alleles ultimately will be of ‘‘great biomedical importance’’
(p. 313). tremely useful, as well as some irrelevant, information. The list of
resources for further information (appendix A) could be far more
JOSEPH D. TERWILLIGER
inclusive, and the appendix entitled ‘‘Points to Consider’’ (appen-
Department of Psychiatry and Columbia Genome Center
dix E), which describes the requirements for Recombinant DNA
Columbia University
Advisory Committee submission of protocols, is of limited interest
New York
to the intended audience. The index linking health disorders to
chromosomal locations (appendix D) is only relevant to individu-
als interested in the efforts to map the human genome; this indexReferences
might have been improved by the linkage of health disorders to
Houwen RHJ, Baharloo S, Blankenship K, Raeymaekers P, Juyn J, speciﬁc disease genes and by the inclusion of relevant references.Sandkuyl LA, Freimer NB (1994) Genome screening by searching
The well-organized, but slightly outdated, list of currently ap-for shared segments: mapping a gene for benign recurrent intrahe-
patic cholestasis. Nat Genet 8:380–386 proved gene therapy trials and contact people (appendix B) is
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clearly the most useful portion of the appendices. This appendix and his wife have made a different choice with which they are
comfortable.would have been strengthened by the inclusion of information on
how to access the latest information on current gene therapy trials, I bought the book because I had heard Be´rube´ speak on Na-
tional Public Radio and had thought that the book sounded inter-principal investigators, and guidelines from both journals (listed
in appendix A) and web sites (e.g., the NIH site Gene Therapy esting. I put it down once after I began reading, only because I
needed to sleep. I have not stopped thinking about it since I ﬁrstfor Human Patients at http://www.nih.gov/od/orda/cover.htm). In
summary, although this book is somewhat uneven, this edition is read it four weeks ago, and I expect that I will read it again. It
has made me think deeply about my role, as a medical geneticist,a valuable starting point for both physicians and patients with an
interest in gene therapy, and it provides a useful overview of the in delivering diagnostic and prognostic information to parents. It
has made me question my own values regarding quality of lifestate of ongoing gene therapy trials.
and my own arbitrary assignment of humanity to others.
KAREN KOZARSKY This is an honest book. I believe that the author has allowed
Institute for Human Gene Therapy me into the most intimate corners of his life and has bravely
University of Pennsylvania articulated his own conﬂicting ideas, feelings, and responses to his
Philadelphia second son. This is a sweet book. It is laced with undeniable love.
Be´rube´ has been most generous in sharing himself and his family
 1997 by The American Society of Human Genetics. All rights reserved. with us. Be´rube´ states, ‘‘My task, ethically and aesthetically, is to
0002-9297/97/6006-0044$2.00 represent James to you with all the ﬁdelity that mere language can
afford, the better to enable you to imagine him—and to imagine
what he might think of your ability to imagine him’’ (p. 264). He
has succeeded.
Buy this book and read this book. I think it should be man-
datory reading for all of us who pretend to know what weAm. J. Hum. Genet. 60:1567, 1997
are doing when we provide genetic counseling to families.
VIRGINIA P. SYBERT
Life as We Know It: A Father, a Family, and an Exceptional Divisions of Medical Genetics and Dermatology
Child. By Michael Be´rube´. New York: Pantheon Books, Children’s Hospital and Medical Center
1996. Pp. 284. $24.00. University of Washington
SeattleThis is an extraordinary book. Be´rube´, a professor of English
at the University of Illinois at Urbana-Champaign, has written
 1997 by The American Society of Human Genetics. All rights reserved.an intimate book about his family, comprised of himself and
0002-9297/97/6006-0045$2.00
his wife, Janet Lyon, and their two sons, Nick and James.
James has trisomy 21 and Nick does not.
In this beautifully written book, Be´rube´ explores and inter-
weaves the intensely personal effect, on a family, of a child with
Down syndrome; the effect of society on that child and family;
Am. J. Hum. Genet. 60:1567–1568, 1997and, in turn, the impact of that child on society. With skillful
prose, always tempered with laugh-out-loud humor, Be´rube´ not
only argues compellingly for Jamie’s place at ‘‘our’’ table, but also Chromosome Abnormalities and Genetic Counseling. By R. J.
demands that we look long and hard at our deﬁnition of table McKinlay Gardner and Grant R. Sutherland. Vol. 29 in:
and at our deﬁnition of us. How do we deﬁne who and what is Oxford Monographs on Medical Genetics. New York: Ox-
human? How do our societal values sculpt our willingness to ford University Press, 1996. Pp. 478. $59.50.
engage and to embrace those who are ‘‘different,’’ and what are
our personal and societal obligations to do so? Genetic counseling in cases of chromosome aberrations can be
very difﬁcult and tricky, as is well known not only to insiders.Be´rube´ skillfully juxtaposes anecdotes and vignettes from
Jamie’s short life, with explorations of philosophy (the Witt- Particularly difﬁcult to handle are prenatal diagnoses, especially
when they are based only on cytogenetic results without the sup-genstein is occasionally tough going, at least for this reader), legisla-
tion, science, and history. In the chapter ‘‘Genetic Destiny,’’ Be´rube´ port of molecular investigations. It is notoriously difﬁcult to ﬁnd
adequate references and guidelines for the many unique situationsoffers one of the clearest explanations of meiotic nondisjunction
that I have ever read. He walks us through the excitement of his that may occur. It is therefore very praiseworthy that its authors
undertook the effort to dedicate a book to the issue of geneticwife’s second pregnancy, their decisions to eschew amniocentesis
and prenatal diagnosis, their reactions to the birth of their son counseling in chromosome aberrations. Indeed, Genetic Counsel-
ing in Chromosome Aberrations might have been a better title.with trisomy 21, and their subsequent experiences throughout
their son’s stormy neonatal course and early childhood. The au- The ﬁrst section of the book (‘‘Basic Concepts) offers an intro-
duction to the principles of human cytogenetics. The followingthor’s narrative is peopled with physical therapists, occupational
therapists, teachers, friends, neighbors, and physicians. He dis- sections are entitled ‘‘The Parentwith aChromosomeAberration,’’
‘‘The Normal Parent with the Chromosomally Abnormal Child,’’courses at length with regard to the issues of prenatal diagnosis
and pregnancy termination, coming down clearly on the side of ‘‘Reproductive Failure’’ (due to chromosomal aberrations), ‘‘Pre-
natal Diagnosis,’’ and, at the end, appendices that mainly includefreedom of choice while, at the same time, recognizing that he
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